EU’s Pharmacovigilance System: A ‘New Era Of Safety & Transparency’
There Have Been 450 Safety Recommendations in Six Years
The EU’s pharmacovigilance system appears to have performed well since it was strengthened in 2012, with 26,000 potential signals assessed and more than 450 safety recommendations issued. However, there is still room for improvement, and it would be useful to compare the system with that of other regulators, say the authors of a study on the first six years of the EMA’s pharmacovigilance committee.
You may also be interested in...
Roche plans to appeal against a penalty imposed by the Romanian competition authorities for implementing strategies that were said to delay the entry of competing biosimilar and generic products.
The EU association representing parallel traders says cheaper parallel imports are vital in keeping medicines affordable for member states.
The latest drug safety actions by the European Medicines Agency affect products for dermatological use and vaginal atrophy.